News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gene Therapy Biopharma uniQure Sets Terms For $64 Million IPO


1/27/2014 7:22:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

uniQure, which develops gene therapies for the treatment of orphan diseases, announced terms for its IPO on Friday. The Amsterdam, Netherlands-based company plans to raise $64 million by offering 4.6 million shares at a price range of $13 to $15. At the midpoint of the proposed range, uniQure would command a market value of $235 million.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq
Read at News Release

comments powered by Disqus
uniQure
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES